Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NTLA | AMGN | GILD | VRTX | BIIB |
| Company | Intellia Thera CS | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 21.22 | 264.63 | 66.25 | 394.72 | 190.72 |
| High | 21.63 | 269.38 | 66.83 | 396.98 | 194.52 |
| Low | 20.78 | 260.68 | 66.16 | 391.25 | 189.44 |
| Last | 21.57 | 268.93 | 66.76 | 394.28 | 194.38 |
| Change | +0.25 | +6.18 | +0.60 | +0.80 | +3.86 |
| % Change | +1.17% | +2.35% | +0.91% | +0.20% | +2.03% |
| Volume | 1,456,898 | 3,379,993 | 10,656,795 | 1,323,862 | 1,599,570 |
| 20-Day Average Volume | 1,183,295 | 2,246,420 | 6,455,910 | 930,913 | 1,140,994 |
| Previous Close | 21.32 | 262.75 | 66.16 | 393.48 | 190.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.82 | 272.56 | 69.90 | 405.52 | 205.03 |
| 20-Day Raw Stochastic | 10.60% | 29.59% | 10.79% | 10.74% | 15.51% |
| 20-Day Relative Strength | 33.60% | 43.95% | 31.30% | 37.76% | 32.40% |
| Weighted Alpha | -52.27 | +7.67 | -24.32 | +15.95 | -36.99 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Last Month's Opinion | 40% Sell | 8% Sell | 72% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.12% since 04/12/24 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -0.57% since 04/12/24 | -1.92% since 04/12/24 |
| Low | 20.78 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 24.15 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 402.49 on 04/15/24 | 199.53 on 04/15/24 |
| 1-Month | |||||
| %Chg | -21.93% since 03/19/24 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | -5.04% since 03/19/24 | -11.09% since 03/19/24 |
| Low | 20.78 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 28.54 on 03/21/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | -15.58% since 01/19/24 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | -9.37% since 01/19/24 | -22.24% since 01/19/24 |
| Low | 20.78 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 34.87 on 02/29/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | -20.41% since 10/19/23 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | +8.08% since 10/19/23 | -24.45% since 10/19/23 |
| Low | 20.78 on 04/19/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 34.87 on 02/29/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,056,080 | 140,812,720 | 82,374,304 | 101,698,464 | 27,694,178 |
| Shares Outstanding, K | 96,439 | 535,919 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 36,280,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -481,190,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 11,990,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -122,220,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 1.77 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.46 on 02/22/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 29.25 | 13.05 |